ViewSonic Makes Eco-Friendly Projection Accessible with New 4,000-Lumen Models

Designed to Fulfill Daily Business and Education Needs with Flexible Throw Ratio…

Prysmian Reinforces Its Long-Term Commitment to Asia Pacific, Supporting the Next Wave of Energy and Digital Infrastructure Growth

SINGAPORE, Jan. 27, 2026 /PRNewswire/ — As Asia Pacific accelerates its energy…

Elliott Management Releases Presentation on Toyota Industries Corporation

Elliott does not intend to tender its shares into the Revised TOB…

Chainlink Labs Joins WEMADE-Led KRW Stablecoin Alliance 'GAKS' to Advance Korean Digital Asset Standards

Chainlink Labs will provide strategic support on technical standard establishment and infrastructure…

Envision's AI-Powered Green Ammonia and Hydrogen Breakthrough Named Global Benchmark by World Economic Forum

DAVOS, Switzerland, Jan. 27, 2026 /PRNewswire/ — Envision’s pioneering green hydrogen and…

A New Era in Options Trading! Moomoo Partners with Nasdaq to Deliver Monday & Wednesday Expirations for Greater Flexibility and Opportunity

JERSEY CITY, N.J., Jan. 27, 2026 /PRNewswire/ — Moomoo’s 28 million investors…

Qilu Evening News•Qilu Yidian: Ramble Shandong | Time in Cultural Relics EP1: The Red Pottery Zoomorphic Pot

JINAN, China, Jan. 27, 2026 /PRNewswire/ — When the Pottery Red Color Zoomorphic…

Nuance Pharma Announces Acceptance for Review of the New Drug Application for Ohtuvayre® (ensifentrine) by the National Medical Products Administration of China for the maintenance treatment of chronic obstructive pulmonary disease

SHANGHAI, Jan. 27, 2026 /PRNewswire/ — Nuance Pharma ("Nuance") today announced that the…